The Duke Funding Alert newsletter, published every Monday, provides information on all new and updated grants and fellowships added to the database during the prior week. This listserv is restricted to members of the Duke community.
THE VICTORIA’S SECRET GLOBAL FUND FOR WOMEN’S CANCERS 2022 MERITORIOUS AWARDS, IN PARTNERSHIP WITH PELOTONIA & AACR
The Victoria’s Secret Global Fund for Women’s Cancers 2022 Meritorious Awards, In Partnership with Pelotonia & AACR are intended to foster innovative research aimed at transforming outcomes for breast and gynecologic cancers, while also serving as an investment in the next generation of female cancer researchers worldwide. Importantly, this initiative will focus on the understanding, prevention, detection, diagnosis, and treatment of women’s cancers, with a goal of eliminating cancer health disparities and improving patient outcomes.
This program will include the recognition of five prominent and influential female cancer researchers who have made outstanding contributions to the fundamental understanding, prevention, and/or treatment of breast or any form of gynecologic cancer.
All award recipients will receive $100,000 and be formally recognized during the AACR Annual Meeting 2022 (AM2022) and Annual Pelotonia Signature Event Weekend. Award acceptances are contingent upon the recipients ability to be present at the AM2022 and discuss their selection (i.e., during press conferences and other promotional activities), unless otherwise unable to do so due to health and/or travel restrictions or other serious conflicts.
Upon their selection, each award recipient will be asked to nominate 3-5 outstanding early-stage investigators to be considered for scientific research grant funding.
Deadline for Nominations: Jan. 14, 2022
Awards will be presented to individual investigators who are affiliated with any institution involved in basic, prevention, translational, or clinical cancer research in the United States or abroad. Such institutions include those in the academic, industry, or government sectors.
Awards will be presented to female cancer researchers who have made significant contributions to the understanding, prevention, detection, diagnosis, and/or treatment of women’s cancers including, but not limited to breast, cervical, endometrial, ovarian, uterine, vaginal, and vulvar cancers.
Institutions and/or organizations are ineligible to receive these awards.